Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 240,771 | 305,665 | 267,474 | 266,267 | 232,997 |
| Cost of Goods | 29,460 | 32,125 | 26,977 | 29,967 | 30,222 |
| Gross Profit | 211,311 | 273,540 | 240,497 | 236,300 | 202,775 |
| Operating Expenses | 189,920 | 177,733 | 178,191 | 171,200 | 173,912 |
| Operating Income | 21,851 | 95,932 | 63,283 | 66,067 | 29,085 |
| Interest Expense | 33 | 31 | 37 | 26 | 37 |
| Other Income | 3,174 | 402 | 2,948 | 1,615 | 1,765 |
| Pre-tax Income | 24,992 | 96,303 | 66,194 | 67,656 | 30,813 |
| Income Tax | -1,627 | 20,117 | 15,467 | 14,082 | 6,734 |
| Net Income Continuous | 26,619 | 76,186 | 50,727 | 53,574 | 24,079 |
| Minority Interests | 145 | 143 | 137 | 200 | 146 |
| Net Income | $26,474 | $76,043 | $50,590 | $53,374 | $23,933 |
| EPS Basic Total Ops | 0.25 | 0.75 | 0.50 | 0.53 | 0.24 |
| EPS Basic Continuous Ops | 0.26 | 0.75 | 0.50 | 0.53 | 0.24 |
| EPS Diluted Total Ops | 0.27 | 0.73 | 0.49 | 0.51 | 0.23 |
| EPS Diluted Continuous Ops | 0.27 | 0.73 | 0.49 | 0.52 | 0.23 |
| EBITDA(a) | $42,297 | $117,115 | $86,248 | $88,539 | $50,944 |